ReviewPharmaceuticals (Basel, Switzerland)2022

Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy.

Jiabin Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.